Call Us: (513) 621-5112

 
 
 
 
 
 
Frequently Used Terms
 
 
Multicenter:

More than one research site is participating in the study.

International:

Sites from countries outside of the US are also participating.

Double-blind:

Neither the research site nor the participant know what treatment the patient is receiving (there are methods of "unblinding" if medically necessary).

Randomized:

The treatment group the patient is assigned to is done randomly, like tossing a coin.

Placebo Controlled:

One treatment group consists of placebo, an inactive substance.

Crossover Design:

Patients will be changed from one treatment to another during the study as part of the study design.

Sponsor:

The company or agency of the US government (such as the National Institutes of Health (NIH)) that provides funding for the study.
 

I Want to Participate >>



Study Participants
 

Contact Us Today!

     
 
 
 

CONTACT US
NEWS & ARTICLES
Call For Participation
Patient Recruitment Specialist
Cincinnati, OH

PH: (513) 621-5112
FX:  (513) 621-5101

Cincinnati / Mt. Auburn
2230 Auburn Avenue
Level B
Cincinnati, OH 45219
PH: (513) 381-4100
FX:  (513) 381-4120

Springdale
375 Glensprings Drive
2nd Floor
Cincinnati, OH 45246
PH: (513) 671-8080
FX:  (513) 671-8090
Gout Increasingly Common Among Americans
Friday, September 8, 2017

Gout is a type of arthritis with both acute and chronic features. The problem is caused by too much uric acid in your blood stream. An acute flare occurs when the excess uric acid forms into crystals which deposit in a joint like your wrist, knee, ankle or most commonly the big toe.

 
 
 



Copyright © 2017. STERLING RESEARCH. All Rights Reserved